MedTrace Logo

Effects of Sevoflurane and Ketamine on QT in Electroconvulsive Therapy

NCT01870219 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2013-06-06

No results posted yet for this study

Summary

The aim of this study was to evaluate the effect of sevoflurane or ketamine on the QTc and Tp-e interval during in patients with major depression.

Conditions

Interventions

DRUG

Sevoflurane

sevoflurane was initiated at %8 sevoflurane for anesthesia induction and maintained at 2% to %4 until the electrical stimulus was delivered

DRUG

Ketamine

ketamine was given to 1mg/kg ıv bolus

Sponsors & Collaborators

  • Inonu University

    lead OTHER

Principal Investigators

  • Feray Erdil, MD · Associated Prof Dr

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2013-04-30
Completion
2013-05-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01870219 on ClinicalTrials.gov